Xencor (XNCR) Revenue (2013 - 2026)
Xencor (XNCR) posted quarterly Revenue of $4.5 million for Q1 2026, down 86.2% year-over-year from $32.7 million in Q1 2025, and down 84.01% quarter-over-quarter from $28.2 million in Q4 2025.
Xencor (XNCR) Revenue (2013 - 2026) Analysis & Trends
Xencor (XNCR) has reported Revenue for 14 consecutive years, with $4.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue fell 86.2% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $97.4 million (down 23.48% YoY), while the FY2025 annual figure was $125.6 million, up 13.65% from the prior year.
- Revenue retreated to $4.5 million in Q1 2026 per XNCR's latest filing, from $28.2 million in the prior quarter.
- Across five years, Revenue topped out at $85.5 million in Q1 2022 and bottomed at $4.5 million in Q1 2026.
- Historically, Revenue has averaged $34.1 million across 5 years, with a median of $28.2 million in 2025.
- Annual changes were most pronounced in 2022 — Revenue jumped 151.46% — and 2026, when it sank 86.2%.
- Xencor's Revenue stood at $21.6 million in 2022, then jumped by 136.07% to $51.0 million in 2023, then grew by 3.49% to $52.8 million in 2024, then tumbled by 46.51% to $28.2 million in 2025, then sank by 84.01% to $4.5 million in 2026.
- Business Quant data shows XNCR's Revenue at $4.5 million in Q1 2026, $28.2 million in Q4 2025, and $21.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Xencor | 1.73 Bn | 1.36 Bn | - | 51.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.22 Mn |
| Mar 31, 2026 | 4.52 Mn |
| Dec 31, 2025 | 28.24 Mn |
| Sep 30, 2025 | 21.00 Mn |
| Jun 30, 2025 | 43.61 Mn |
| Mar 31, 2025 | 32.73 Mn |
| Dec 31, 2024 | 52.79 Mn |
| Sep 30, 2024 | 17.80 Mn |
| Jun 30, 2024 | 23.91 Mn |
| Mar 31, 2024 | 16.00 Mn |
| Dec 31, 2023 | 51.02 Mn |
| Sep 30, 2023 | 59.20 Mn |
| Jun 30, 2023 | 45.50 Mn |
| Mar 31, 2023 | 19.00 Mn |
| Dec 31, 2022 | 21.61 Mn |
| Sep 30, 2022 | 27.30 Mn |
| Jun 30, 2022 | 30.20 Mn |
| Mar 31, 2022 | 85.50 Mn |
| Dec 31, 2021 | 154.01 Mn |
| Sep 30, 2021 | 19.68 Mn |